Heyue Zhou

This inventor holds 62 USPTO granted patents and 17 published patent applications, plus 4 CIPO patents and 9 EPO patents, primarily in Antibody Therapeutics (CPC class C07K). Top assignees: Sorrento Therapeutics, Inc., Vivasor, Inc., Jmb Capital Partners Lending, LLC. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Heyue Zhou. Retrieved from https://idiyas.com/inventor/heyue-zhou

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 62 (Patent Applications = 17)

% Patents Active = 87.1

CIPO Patents = 4 (Patent Applications = 30)

EPO Patents = 9 (Patent Applications = 42)

Average Co-Inventor Count = 2.6

ph-index = 6

Forward Citations = 290(Granted Patents)

Forward Citations (Not Self Cited) = 252(Dec 10, 2025)

Inventors with similar research interests:

Company Filing History:

56 out of 114

Sorrento Therapeutics, Inc.

Jmb Capital Partners Lending, LLC

Years Active: 2014-2026

Loading Chart...

Areas of Expertise:

Antibody

CD38

PD-L1

VEGFR2

Cancer Treatment

Binding Proteins

Chimeric Antigen Receptor

Therapeutics

Anti-KRAS

CTLA4

JAG1

CCR2

62 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12734209 - CD38 Antibody Drug Conjugate (2026-09-15),

2. 12630642 - Antigen Binding Proteins that Bind BCMA (2026-05-19),

3. 12624103 - Engineered Antibodies That Bind LAG3 (2026-05-12),

4. 12600790 - Variant Antibody That Binds Cd38 (2026-04-14),

5. 12084503 - Fully human antibodies that bind to vascular endothelial growth factor receptor 2 (VEGFR2) and methods of use thereof for treatment (2024-09-10),

6. 11999792 - Antibody therapeutics that bind CD38 (2024-06-04),

7. 11919952 - Antigen binding proteins that bind PD-L1 (2024-03-05),

8. 11878058 - Antigen binding proteins that bind PD-L1 (2024-01-23),

9. 11760806 - CD-38 directed chimeric antigen receptor constructs (2023-09-19),

10. 11746156 - Antibody therapeutics that bind CD123 (2023-09-05),

11. 11318202 - Antigen binding proteins that bind WISP1 (2022-05-03),

12. 11242391 - Antigen binding proteins that bind PD-1 (2022-02-08),

13. 11191845 - CD38 antibody drug conjugate (2021-12-07),

14. 11180568 - Antibody therapeutics that bind CD137 (2021-11-23),

15. 11174314 - Anti-KRAS binding proteins (2021-11-16),

Title: Inventor Heyue Zhou - Revolutionizing Technology in San Diego

Introduction: Heyue Zhou is a visionary inventor based in San Diego, CA, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Heyue Zhou holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: With a career spanning over two decades, Heyue Zhou has worked with leading tech companies, research institutions, and universities to develop cutting-edge solutions that have had a significant impact on various industries.

Collaborations: Heyue Zhou has collaborated with top scientists, engineers, and researchers from around the world, fostering a culture of innovation and knowledge-sharing to drive progress in the field of technology.

Conclusion: Heyue Zhou's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology in San Diego and beyond.

Profile summary based on public USPTO records.